Evidence map›Paper›PMID 35101899›Full record

Observational studyOpen heart2022

Drivers and outcomes of variation in surgical versus transcatheter aortic valve replacement in Ontario, Canada: a population-based study.

Rafael N Miranda, Feng Qiu, Ragavie Manoragavan, Stephen Fremes, Sandra Lauck, Louise Sun, Christopher Tarola, Derrick Y Tam, Mamas Mamas, Harindra C Wijeysundera

Open access · goldAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Open heart, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Rafael N MirandaInstitute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0003-2173-0021
Feng QiuInstitute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.
Ragavie ManoragavanSchulich Heart Program, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
Stephen FremesInstitute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
Sandra LauckCentre for Heart Valve Innovation, Saint Paul's Hospital, Vancouver, British Columbia, Canada.
Louise SunInstitute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.ORCID 0000-0003-3381-3115
Christopher TarolaSchulich Heart Program, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
Derrick Y TamSchulich Heart Program, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
Mamas MamasKeele Cardiovascular Research Group, School of Medicine, Keele University, Keele, UK.ORCID 0000-0001-9241-8890
Harindra C WijeysunderaInstitute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada Harindra.wijeysundera@sunnybrook.ca.ORCID 0000-0001-8464-1080
Sunnybrook Health Science Centre · CAInstitute for Clinical Evaluative Sciences · CAKeele University · GBSt. Paul's Hospital · CAUniversity Health Network · CAUniversity of Ottawa · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo understand the patient and hospital level drivers of the variation in surgical versus trascatheter aortic valve replacement (SAVR vs TAVR) for patients with aortic stenosis (AS) and to explore whether this variation translates into differences in clinical outcomes.

backgroundAdoption of TAVR has grown exponentially worldwide. Notwithstanding, a wide variation in TAVR rates has been seen within and between countries and in some jurisdictions AS is still primarily being managed by SAVR.

methodsWe conducted a population-based retrospective cohort study in Ontario, Canada, including individuals who received TAVR or SAVR between 2016 and 2020. We developed iterative hierarchical logistic regression models for the likelihood of receiving TAVR instead of SAVR examining sequentially patient characteristics, hospital factors and year of procedure, calculating the median ORs and variance partition coefficients for each. Using Cox proportional hazards models, we examined the relationship between TAVR/SAVR ratio on all-cause mortality and readmissions.

resultsAnnual procedures rates per million population increased from 171 to 201, mainly driven by the expansion of TAVR. TAVR/SAVR ratios differed substantially between hospitals, from 0.21 to 3.27. Neither patient nor hospital factors explained the between-hospital variation in AS treatment. The TAVR/SAVR ratio was significantly associated with clinical outcomes with high ratio hospitals having lower mortality and rehospitalisations.

conclusionsDespite the expansion of TAVR, dramatic variation exists that is not explained by patient or hospital factors. This variation was associated with differences in clinical outcomes, suggesting that further work is needed in understanding and addressing inequity of access.

Indexed as

AgedAged, 80 and overAortic ValveAortic Valve StenosisFemaleFollow-Up StudiesHumansMaleOntarioPopulation SurveillanceRetrospective StudiesRisk FactorsTranscatheter Aortic Valve ReplacementTreatment Outcomeaortic valve stenosishealth careheart valve prosthesis implantationoutcome assessmenttranscatheter aortic valve replacement

Identifiers

PMID35101899
PMCPMC8804707
OpenAlexW4210293772

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.